Impact of Combined “CHADS-BLED” Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve Replacement

Table 2

Discrimination performance (ROC and AUC statistics): subanalysis of patients with AF.

Groups/endpoints	Variables	AUC	value	Lower 95% CI	Upper 95% CI
(C) TF TAVR
30-day mortality	Log. EuroSCORE I	0.64	0.105	0.49	0.79
	STS score	0.73	0.006	0.60	0.87
	CHA2DS2-VASC	0.78	0.001	0.70	0.87
	HAS-BLED	0.74	0.004	0.59	0.89
	“CHADS-BLED”	0.83	<0.0001	0.76	0.91
CVI	Log. EuroSCORE I	0.52	0.720	0.40	0.65
	STS score	0.61	0.102	0.49	0.73
	CHA2DS2-VASC	0.59	0.195	0.46	0.71
	HAS-BLED	0.66	0.019	0.54	0.77
	“CHADS-BLED”	0.64	0.040	0.52	0.76
MVASC/BARC	Log. EuroSCORE I	0.69	0.007	0.56	0.82
	STS score	0.72	0.001	0.61	0.84
	CHA2DS2-VASC	0.54	0.543	0.43	0.65
	HAS-BLED	0.64	0.043	0.52	0.76
	“CHADS-BLED”	0.62	0.101	0.50	0.73
(D) TA TAVR
30-day mortality	Log. EuroSCORE I	0.31	0.072	0.12	0.50
	STS score	0.43	0.497	0.27	0.59
	CHA2DS2-VASC	0.31	0.070	0.17	0.45
	HAS-BLED	0.40	0.356	0.22	0.58
	“CHADS-BLED”	0.31	0.077	0.17	0.45
CVI	Log. EuroSCORE I	0.45	0.82	0.26	0.64
	STS score	0.64	0.489	0.43	0.86
	CHA2DS2-VASC	0.39	0.591	0.00	0.80
	HAS-BLED	0.25	0.235	0.00	0.60
	“CHADS-BLED”	0.31	0.369	0.00	0.72
MVASC/BARC	Log. EuroSCORE I	0.42	0.336	0.30	0.54
	STS score	0.47	0.756	0.33	0.62
	CHA2DS2-VASC	0.42	0.371	0.27	0.58
	HAS-BLED	0.56	0.485	0.39	0.73
	“CHADS-BLED”	0.49	0.865	0.31	0.66